EC Healthcare (02138) released its monthly return for February 2026. The authorized share capital remained at 38.00 billion ordinary shares, each with a par value of HKD 0.00001 and totaling HKD 380,000. The number of issued shares stood at 1.19 billion, with no treasury shares held, indicating no overall change in the company’s share capital during the period.

All required public float regulations continued to be met at a 25% threshold. Under existing share option schemes, 18.96 million options remained outstanding from the scheme approved on 19 February 2016, and 59.26 million options from the scheme approved on 29 May 2023; no options were exercised in February, resulting in no additional shares issued.

Meanwhile, the warrants in an aggregate nominal value of HKD 36.40 million lapsed, and convertible bonds of HKD 234.00 million and HKD 31.20 million matured during the month, with no additional shares issued through these instruments. Overall, there were no changes to the company’s issued share capital or treasury shares.